Overall cohort | rpAD | Non-rpAD | P-value (after MLRA) | |
---|---|---|---|---|
Tau (pg/ml) median (IQR) | 514 (387) | 629 (562.3) | 476 (338.5) | 0.014* (0.074) |
P-Tau (pg/ml) median (IQR) | 79 (40) | 85.5 (54.55) | 77 (37) | 0.090 (0.059) |
Tau-ratio (P-Tau/Tau) median (IQR) | 0.16 (0.09) | 0.16 (0.1) | 0.17 (0.08) | 0.571 (0.336) |
Aβ1-42 (pg/ml) median (IQR) | 582 (343) | 500 (274) | 614 (338) | 0.008* (0.048)* |
Aβ1-40modified (pg/ml)a median (IQR) | 9415 (4152) | 9145 (4035) | 9459 (4218) | 0.921 (0.339) |
Aß-ratiomodfieda median (IQR) | 0.62 (0.41) | 0.54 (0.25) | 0.65 (0.45) | 0.008* (0.038)* |
Tau/Aβ1-42- Ratio median (IQR) | 0.9 (0.94) | 1.32 (1.07) | 0.75 (0.77) | < 0.001* (0.004)* |
P-Tau/Aβ1-42- Ratio median (IQR) | 0.15 (0.13) | 0.18 (0.18) | 0.14 (0.13) | 0.007* (0.004)* |